Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...
Patients with non-metastatic GIST treated with neoadjuvant TKIs prior to surgery experienced a benefit which led to less ...
Therefore, it is critical to identify novel actionable alterations in SDH-deficient GIST. Seventeen tumor samples from 14 patients with SDH-deficient GIST underwent NGS. Mutational load was low, ...
Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.